健康160（02656）于2026年7月17日发布翌日披露报表，公告显示，公司根据2023年8月31日批准及采纳的首次公开发售前购股权计划，增发10,787,770股普通股，占发行前已发行股本的3.21%。本次新发行股份每股价格为0.000002美元。增发完成后，健康160的已发行股本由336,452,810股增至347,240,580股，库藏股数量保持不变。
公告同时披露，其已获董事会正式授权进行本次股份发行，并确认遵守香港联交所证券上市规则及相关法律规定。上述公告由公司董事长、执行董事兼首席执行官罗宁政先生签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.